EUVIMEDEUVIMED entdecken
Crossref

Design and Synthesis of Bimetallic Cu(II) Compounds as Potent Antibacterial and Antibiofilm Agents with Metallo‐ β ‐Lactamase Inhibitory Activity Against Multidrug Resistant Pseudomonas aeruginosa

Samik Biswas, Sujan Sk, Sangita Das, Indrajit Das, Shrabasti Bandyopadhyay, Soma Mondal, Sk Imran Ali iD, Supratim Mandal iD, Manindranath Bera iD

Chemistry – A European Journal · 2025

DOI: 10.1002/chem.202501313 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Chemistry – A European Journal, 2025. Verfasst von Samik Biswas und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Microbiology, University of Kalyani, Kalyani, Nadia, West Bengal, 741235, India. Hauptthemen laut MEDLINE: Pseudomonas aeruginosa, Copper, Anti-Bacterial Agents, beta-Lactamases. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 59 Literaturangaben. Gefördert von: Indian Council of Medical Research.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

In this research, a novel class of biologically active bimetallic Cu(II) compounds has been discovered as cutting‐edge antibiofilm agents with metallo‐ β ‐lactamase (MBL) inhibitory activity against the clinically isolated multidrug‐resistant (MDR) gram‐negative bacterium, Pseudomonas aeruginosa (Pa‐CI‐1). As the traditional strategies for antibiotic development are proving inadequate against the swift evolution of bacterial resistance, there is an urgent need to establish novel antibacterial strategies with mechanism different from those of prevailing antibiotics. Thus, the 2,6‐bis[N‐{N‐(carboxymethyl)‐N‐(pyridylmethyl)amine}methyl]‐4‐methylphenol (H 3 L)‐incorporated three bimetallic Cu(II) compounds, [Cu 2 L(H 2 O)(Cl)]·H 2 O ( 1 ), [Cu 2 L(H 2 O)(NO 3 )]·H 2 O ( 2 ) and [Cu 2 L(H 2 O)(CH 3 CO 2 )]·H 2 O ( 3 ) has been strategically designed and synthesized with an unsymmetrical coordination arrangement that synergistically modifies the electronic environment of Cu centers for the enhancement of antibacterial and antibiofilm activity. The electronic environment of Cu(II) and its adjoining atoms has been further modified by substituting Cl − in 1 by NO 3 − in 2 and CH 3 CO 2 − in 3 . The standard nitrocefin assay disclosed that 1–3 significantly inhibited the activity of MBLs produced by Pa‐CI‐1 at the half minimum inhibitory concentration (1/2 MIC). Molecular docking study suggested an excellent propensity of these Cu compounds for binding with MBL‐producing proteins such as Verona integron‐encoded metallo‐ β ‐lactamase (VIM‐1), Sao Paulo metallo‐ β ‐lactamase (SPM‐1), imipenemase (IMP‐1), AmpC, and New Delhi metallo‐ β ‐lactamase (NDM‐1). However, the best possible interaction was observed for VIM‐1 protein. All three Cu(II) compounds displayed significantly high antibacterial and antibiofilm activity as established by multiple bioassays, including ex vivo applicability studies. However, 1 and 3 showed an outstanding activity with MIC values of 200 and 150 µg/mL, respectively, in comparison to 2 with an MIC of 300 µg/mL. They showed an exceptional combinatorial activity when examined with five different commercially accessible β ‐lactam‐based antibiotics, such as amoxicillin (AMX), chloramphenicol (CHL), cefotaxime (CTX), ceftriaxone (CTR), and cefoxitin (CX) against Pa‐CI‐1. It has been suggested that the as‐synthesized Cu compounds also blocked the activity of MBLs via strong interactions with the active sites of enzymes, thus restoring the normal activity of the antibiotics. Our study disclosed that 1–3 could be the emergent drug leads and attract great attention to the materials and biological chemists, combating antimicrobial resistance (AMR).

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Pseudomonas aeruginosaCopperAnti-Bacterial Agentsbeta-LactamasesBiofilmsbeta-Lactamase InhibitorsCoordination ComplexesMicrobial Sensitivity TestsDrug Resistance, Multiple, BacterialMolecular Docking SimulationDrug Design

Stichwörter der Autor:innen

Ex vivo application potentialbimetallic Cu(II) compoundbiofilm infection and multidrug resistanceclinically isolated Pseudomonas aeruginosametallo‐β‐lactamase inhibitionpyridine‐and carboxylate‐based organic scaffold

Substanzen

CopperAnti-Bacterial Agentsbeta-Lactamasesbeta-Lactamase InhibitorsCoordination Complexes

Autor:innen und Institutionen

  • Department of Microbiology, University of Kalyani, Kalyani, Nadia, West Bengal, 741235, India.
  • Analytical Chemistry Section, Department of Chemistry, University of Kalyani, Kalyani, Nadia, West Bengal, 741235, India.
  • Department of Microbiology, College of Medicine and JNM (Jawaharlal Nehru Memorial) Hospital, Kalyani, Nadia, West Bengal, 741235, India.

ORCID-Profile: Sk Imran Ali, Supratim Mandal, Manindranath Bera

Förderung

  • Indian Council of Medical Research

Zitieren

APA

Biswas, S., Sk, S., Das, S., Das, I., Bandyopadhyay, S., Mondal, S., Ali, S. I., Mandal, S., & Bera, M. (2025). Design and Synthesis of Bimetallic Cu(II) Compounds as Potent Antibacterial and Antibiofilm Agents with Metallo‐ β ‐Lactamase Inhibitory Activity Against Multidrug Resistant Pseudomonas aeruginosa. Chemistry – A European Journal. https://doi.org/10.1002/chem.202501313

Vancouver

Biswas S, Sk S, Das S, Das I, Bandyopadhyay S, Mondal S, et al. Design and Synthesis of Bimetallic Cu(II) Compounds as Potent Antibacterial and Antibiofilm Agents with Metallo‐ β ‐Lactamase Inhibitory Activity Against Multidrug Resistant Pseudomonas aeruginosa. Chemistry – A European Journal. 2025. doi:10.1002/chem.202501313

BibTeX
@article{Biswas2025,
  author = {Biswas, Samik and Sk, Sujan and Das, Sangita and Das, Indrajit and Bandyopadhyay, Shrabasti and Mondal, Soma and Ali, Sk Imran and Mandal, Supratim and Bera, Manindranath},
  title = {Design and Synthesis of Bimetallic Cu(II) Compounds as Potent Antibacterial and Antibiofilm Agents with Metallo‐ β ‐Lactamase Inhibitory Activity Against Multidrug Resistant Pseudomonas aeruginosa},
  journal = {Chemistry – A European Journal},
  year = {2025},
  doi = {10.1002/chem.202501313}
}
Kostenlos starten →